Protease modulating dressings for treating diabetic foot ulcers

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 11, 2016, Pages

  Bergin, Shan ^a   Thomas, Sian ^b   Royle, Pamela ^c   Waugh, Norman ^c  

^a DANDENONG HOSPITAL   (Australia)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE;

ARTICLE; BANDAGES AND DRESSINGS; DIABETIC FOOT; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

EID: 85000658031     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005361.pub2     Document Type: Article

References (36)

1. Adler AI, Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Smith DG. Risk factors for diabetic peripheral neuropathy- results of the Seattle Prospective Diabetic Foot Study. Diabetes Care 1997;20(7):1162-7.
2. Apelqvist J, Bakker K, van Houtum WH, Nabuurs-Franssen MH, Schaper NC on behalf of the International Working Group on the Diabetic Foot. International consensus and practical guidelines on the management and prevention of the diabetic foot. Diabetes/Metabolism Research and Reviews 2000;16(Supp 1):S84-92.
3. Armstrong DG, Lavery L, Harkless L. Validation of a diabetic wound classification system - the contribution of depth, infection and ischaemia to risk of amputation. Diabetes Care 1998;21(5):855-9.
4. Armstrong DG, Jude EB. The role of matrix metalloproteinases in wound healing. Journal of the American Podiatic Medical Association 2002;92(1):12-18.
5. Boulton AJM, Cavangh PR. The foot in diabetes. 3rd Edition. Chichester: Wiley and Sons, 2000.
6. Chin GA, Thigpin TG, Perrin KJ, Moldawer LL, Schultz GS. Treatment of chronic ulcers in diabetic patients with a topical metalloproteinase inhibitor, Doxycycline. Wounds 2003;15(10):315-23.
7. Cullen B, Smith R, McCulloch E, Ilcock D, Morrison L. Mechanism of action of Promogran, a protease modulating matrix for the treatment of diabetic foot ulcers. Wound Repair and Regeneration 2002;10:16-25.
8. DiabCost Australia. Assessing the Burden of Diabetes in Australia.. http://www.diabetesnsw.com.au/docs/pdfs/2003109113947.pdf2002.
9. Dowsett C. An Overview of Acticoat Dressing in Wound Management. British Journal of Nursing (Tissue Viability Supplement) 2003;12(19):S44-S49.
10. Duby JJ, Campbell RK, Setter SM, White JR, Rasmussen KA. Diabetic neuropathy: an intensive review. American Journal of Health-System Pharmacy 2004;61(2):160-73.
11. Eaglestein WH. Moist wound healing with occlusive dressings: a clinical focus. Dermatologic Surgery 2001;27(2):175-81.
12. Edwards R, Harding K. Bacteria and wound healing [Skin and Soft Tissue Infections]. Current Opinion in Infectious diseases 2004;17(2):91-6.
13. Frykberg RG. Epidemiology of the diabetic foot: ulcerations and amputations. Advances in Wound Care 1999;12(3):139-41.
14. Frykberg RG, Armstrong DG, Giurini J, Edwards A, Kravette M, Kravitz S, Ross C, Stavosky J, Stuck R, Vanore J, American College of Foot and Ankle Surgeons. Diabetic foot disorders: a clinical practice guideline. American College of Foot and Ankle Surgeons. The Journal of Foot and Ankle Surgery 2000;39(5 (Suppl)):S1-60.
15. Gordois A, Scuffham P, Shearer A, Oglesby A, Tobian J. The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care 2003;26(6):1790-5.
16. Greenhalgh DG. Wound Healing and Diabetes Mellitus. Clinics in Plastic Surgery 2003;30(1):37-45.
17. Gregg EW, Sorlie P, Paulose-Ram R, Gu Q, Eberhardt MS, Wolz M, et al. Prevalence of lower-extremity disease in the U.S. adult population = 40 years of age with and without diabetes. Diabetes Care 2004;27(7):1591-7.
18. Hunt TK, Hopf H, Zamirul H. Physiology of wound healing. Advances in Skin and Wound Care 2000;13((2 Suppl)):6-11.
19. Kastenbauer T, Irsigler P, Sauseng S, Grimm A, Prager R. The prevalence of sensorimotor and autonomic neuropathy in Type 1 and Type 2 diabetic subjects. Journal of Diabetes and its Complications 2004;18(1):27-31.
20. Koproski J, Pretto Z, Poretsky L. Effect of an intervention by a diabetes team in hospitalised patients with diabetes. Diabetes Care 1997;20(10):1553-5.
21. Lobmann R, Ambrosch A, Schultz G, Waldmann K, Schiweck S, Lehnert H. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetalogia 2002;45(7):1011-6.
22. Lobmann R, Schultz G, Lehnert H. Proteases and the diabetic foot syndrome: mechanisms and therapeutic implications. Diabetes Care 2005;28(2):461-71.
23. Mast BA, Schultz GS. Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair and Regeneration 1996;4(4):411-20.
24. Muncaster D. The physiology of wound healing and wound assessment. British Journal of Perioperative Nursing 2001;11(8):362-370.
25. Oyibo SO, Jude EB, Nguyen HC, Armstrong DG, Harkless LB, Boulton AJM. The effects of ulcer size and site, patient's age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers. Diabetic Medicine 2001;18(2):133-8.
26. Ragnarson Tennvall G, Apelqvist J. Health related quality of life in patients with diabetes and foot ulcers. Journal of Diabetes and its Complications 2000;14(5):235-41.
27. Reiber GE, Vileikyte L, Boyko EJ, de Aguila M, Smith DG, Lavery LA, et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999;22(1):157-62.
28. Schultz GS, Sibbald RB, Falanga V, Ayello E, Dowsett C, Harding K, et al. Wound bed preparation: a systematic approach to wound management. Wound Repair and Regeneration 2003;11(Suppl 1):S1-28.
29. Tapp RJ, Shaw JE, de Courten MP, Dunstan DW, Welborn TA, Zimmet PZ on behalf of the AusDiab Study Group. Foot complications in type 2 diabetes: an Australian population-based study. Diabetic Medicine 2003;20(2):105-113.
30. Trengove NJ, Stacey MC, Macauley S, Bennett N, Gibson J, Burslem F, et al. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair and Regeneration 1999;7(6):442-52.
31. Valk GD, Assendelft WJJ. Educational interventions for preventing diabetic foot ulceration. Cochrane Database of Systematic Reviews 2001, Issue 3. [DOI: 10.1002/14651858.CD001488.pub2]
32. Van Acker K, De Block C, Abrams P, Bouten A, DeLeeuw I. The choice of diabetic foot ulcer classification system in relation to outcome. Wounds 2002;14(1):16-25.
33. van den Berg AJ, Halkes SB, van Ufford HC, Hoekstra MJ, Beukelman CJ. A novel formulation of metal ions and citric acid reduces reactive oxygen species in vitro. Journal of Wound Care 2003;12:413-8.
34. Van Gils CC, Wheeler LA, Mellsrom M, Brinton EA, Mason S, Wheeler CG. Amputation prevention by vascular surgery and podiatry collaboration in high risk diabetic and non-diabetic patients-the operation desert foot experience. Diabetes Care 1999;22(5):678-83.
35. The World Health Organisation. http://www.who.int/mediacentre/factsheets/fs236/en/. The World Health Organisation, 2005.
36. Yager DR, Zhang LY, Liang H, Diegelmann RF, Cohen IK. Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wounds. Journal of Investigative Dermatology 1996;107(5):743-8.